Meal Tolerance Trial in Pregnant Women Diagnosed With Gestational Diabetes Mellitus. (GDM-MTT)
A Randomised, Controlled, Open-label Trial to Investigate the Effect of a New Nutritional Supplement on Postprandial Glucose Response in Women Diagnosed With Gestational Diabetes Mellitus.
Sponsor: Danone Asia Pacific Holdings Pte, Ltd.
Terminated
Current protocol is not optimal/feasible
Other terminated trials from Danone Asia Pacific Holdings Pte, Ltd.
- User Experience of Mobile Application · Jun 2020
- Infantile Colic · Phase NA · Jul 2018
- Healthy · Dec 2017
More terminations from Danone Asia Pacific Holdings Pte, Ltd.
Other Gestational Diabetes Mellitus in Pregnancy trials with similar outcome
Browse all Gestational Diabetes Mellitus in Pregnancy trials
Listed as NCT02225951, this NA trial focuses on Gestational Diabetes Mellitus in Pregnancy and remains terminated or withdrawn. Sponsored by Danone Asia Pacific Holdings Pte, Ltd., it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Oct 2017 — Jun 2018 [monthly]
Terminated NA
Phase: PHASE2 → NA
▶ Show 2 earlier versions
-
Jun 2017 — Oct 2017 [monthly]
Terminated PHASE2
-
Jan 2017 — Jun 2017 [monthly]
Terminated PHASE2
First recorded
Jul 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Danone Asia Pacific Holdings Pte, Ltd.
- Nutricia Research
For direct contact, visit the study record on ClinicalTrials.gov .